Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06976528 · ClinicalTrials.gov registry record

Understanding the Associations Between Romantic Relationship Conflict, Psychophysiological Responding and Alcohol Misuse Among Emerging Adults

A clinical trial of Heavy Episodic Drinking, sponsored by New York University.

Recruiting
Registry status
160
Enrollment target
1
Study location

NCT06976528: Recruiting study of Heavy Episodic Drinking, sponsored by New York University.

NCT06976528 is a study of Heavy Episodic Drinking that is actively recruiting participants, run by New York University. The registered enrollment target is 160 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06976528, a study of Heavy Episodic Drinking, is actively recruiting participants, sponsored by New York University.

RECRUITING
Registry status
160 participants
Enrollment target
1
Study location

Study Summary

Emerging Adults (EA) engage in heavy episodic drinking (HED) at a greater quantity and frequency than any other time in their lives, which may lead to significant short- and long-term consequences. Although much is known about the influence of peers in EA alcohol use, there is a dearth of research examining the ways in which romantic partners influence EA drinking behaviors. The proposed study bridges a crucial gap in the existing literature by examining behavioral and physiological risk and resilience factors in the acute link between EA relationship conflict and alcohol consumption. EA couples will engage in two conflict resolution tasks interspersed with two puzzle tasks and two alcohol administration procedures. Because high frequency heart rate variability (HF-HRV) is associated with alcohol use and emotion regulation during stressful experiences, HF-HRV and other physiological data will be collected throughout the laboratory procedures.

Primary Outcome

Amount of alcohol consumed during the study

Conditions Studied

Study Locations (1)

New York

  • 386 Park Avenue South - New York

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2025-09-26
Est. Completion 2028-07-31
New York University

83 total trials

What NCT06976528 shows while recruiting

NCT06976528 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Heavy Episodic Drinking appearing as the primary indexed condition, and to 0 interventions.

NCT06976528 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06976528 about?

NCT06976528 is a clinical study titled "Understanding the Associations Between Romantic Relationship Conflict, Psychophysiological Responding and Alcohol Misuse Among Emerging Adults". Emerging Adults (EA) engage in heavy episodic drinking (HED) at a greater quantity and frequency than any other time in their lives, which may lead to significant short- and long-term consequences. Although much is known about the influence of peers in EA alcohol use, there is a dearth of research e...

What is the current status of trial NCT06976528?

This trial is currently recruiting. The enrollment target is 160 participants. The study started on 2025-09-26. Estimated completion is 2028-07-31.

What conditions does trial NCT06976528 study?

This clinical trial studies the following conditions: Heavy Episodic Drinking.

Who is sponsoring clinical trial NCT06976528?

This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06976528 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heavy Episodic Drinking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00932139 · 160 participants · NA

    Effect of Electro-Acupuncture on Blood Pressure

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06976528, the US trial registry maintained by the National Library of Medicine. NCT06976528 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.